European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD)

You might also be interested in reading MicroStrategy buys $616M more of bitcoin, swelling stash to almost $5.9B.